在巨细胞中同时诱导SLIT3和microRNA-218-2通过托尔类受体4激活,限制了骨质细胞的承诺

Eun-Young Kim1,2, Ji-Eun Kim1,2, Soo-Hyun Chung1,2

  • 1Department of Biochemistry and Molecular Biology, Asan Medical Center and AMIST, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Korea.

概括

收费类受体4 (TLR4) 激活通过诱导Slit3和miR-218-2来抑制骨质细胞的形成,这些细胞准RANK. 这种机制可以防止炎症期间发生过度的骨损失.